By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Syndax Pharmaceuticals45.87M100.00%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States23.68M100.00%